389 related articles for article (PubMed ID: 32503449)
1. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of intravenous pentamidine for Pneumocystis jirovecii pneumonia prophylaxis in adult patients with hematologic malignancies-its utility during respiratory virus pandemics.
Liew YX; Ho AYL; Wong GC; Chung SJ; Tan TT; Tan BH
Int J Infect Dis; 2024 Jun; 143():107059. PubMed ID: 38615824
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
4. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
[No Abstract] [Full Text] [Related]
5. Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation.
DeMasi JM; Cox JA; Leonard D; Koh AY; Aquino VM
Pediatr Infect Dis J; 2013 Sep; 32(9):933-6. PubMed ID: 23538522
[TBL] [Abstract][Full Text] [Related]
6. Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients.
Clark A; Hemmelgarn T; Danziger-Isakov L; Teusink A
Pediatr Transplant; 2015 May; 19(3):326-31. PubMed ID: 25712369
[TBL] [Abstract][Full Text] [Related]
7. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
McCollam S; Lewis JS; Bubalo J; Diaz A
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0083322. PubMed ID: 36214573
[TBL] [Abstract][Full Text] [Related]
9. The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients.
Kruizinga MD; Bresters D; Smiers FJ; Lankester AC; Bredius RGM
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28074607
[TBL] [Abstract][Full Text] [Related]
10. Safety and Effectiveness of Intravenous Pentamidine for Prophylaxis of Pneumocystis jirovecii Pneumonia in Pediatric Hematology/Oncology Patients.
Solodokin LJ; Klejmont LM; Scipione MR; Dubrovskaya Y; Lighter-Fisher J; Papadopoulos J
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e180-5. PubMed ID: 27164533
[TBL] [Abstract][Full Text] [Related]
11. Safe and Effective Prophylaxis with Bimonthly Intravenous Pentamidine in the Pediatric Hematopoietic Stem Cell Transplant Population.
Levy ER; Musick L; Zinter MS; Lang T; Cowan MJ; Weintrub PS; Dvorak CC
Pediatr Infect Dis J; 2016 Feb; 35(2):135-41. PubMed ID: 26418240
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of intravenous pentamidine isethionate for Pneumocystis jiroveci prophylaxis in a pediatric oncology population.
Orgel E; Rushing T
Pediatr Infect Dis J; 2014 Mar; 33(3):319-21. PubMed ID: 24030353
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation.
Marras TK; Sanders K; Lipton JH; Messner HA; Conly J; Chan CK
Transpl Infect Dis; 2002 Jun; 4(2):66-74. PubMed ID: 12220242
[TBL] [Abstract][Full Text] [Related]
15. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant.
Sweiss K; Anderson J; Wirth S; Oh A; Quigley JG; Khan I; Saraf S; Mactal-Haaf C; Rondelli D; Patel P
Bone Marrow Transplant; 2018 Mar; 53(3):300-306. PubMed ID: 29269796
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
[TBL] [Abstract][Full Text] [Related]
18. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
19. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.
Kim SY; Dabb AA; Glenn DJ; Snyder KM; Chuk MK; Loeb DM
Pediatr Blood Cancer; 2008 Apr; 50(4):779-83. PubMed ID: 17635000
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
